Literature DB >> 25207091

Neuropeptide Y Gene Promoter -399T/C Polymorphism Increases Risk of Ischemic Stroke.

Xue-Feng Fu1, Xin Zhang1, Dong-Jun Wang1, Bo Zhao1, Yu-Rong Li1.   

Abstract

BACKGROUND: Several genetic factors underlying ischemic stroke have been identified. Variants of Neuropeptide Y (NPY), whose product plays diverse roles in modulating physiological functions, have been associated with an increased risk of ischemic stroke in South Korean individuals. AIMS: We explored the association between a polymorphism in the NPY gene promoter at position -399 and the risk of ischemic stroke in Han Chinese. STUDY
DESIGN: Case-control study.
METHODS: The polymorphism -399T/C in the promoter of NPY was analysed in 500 patients with ischemic stroke and 500 healthy individuals by amplification and sequencing of this region. Non-conditional logistic regression was used to analyse association between genotypes and the risk of ischemic stroke.
RESULTS: Genotype and allele frequencies differed significantly between the ischemic stroke and control groups (P<0.05). Additionally, compared to stroke patients with the TT genotype, those with the CC genotype had a 1.7-times higher risk of ischemic stroke (OR=1.739, 95%CI=1.201-2.520, P=0.003), especially for those who were over 60 years old or male. Individuals with the TC genotype did not have an increased risk of ischemic stroke (P>0.05).
CONCLUSION: The -399T/C polymorphism of the NPY gene is associated with ischemic stroke in Han Chinese individuals, and the CC genotype may be a risk factor for ischemic stroke.

Entities:  

Keywords:  Gene polymorphisms; Ischemic stroke; Neuropeptide Y

Year:  2013        PMID: 25207091      PMCID: PMC4115980          DOI: 10.5152/balkanmedj.2013.7964

Source DB:  PubMed          Journal:  Balkan Med J        ISSN: 2146-3123            Impact factor:   2.021


  21 in total

1.  Peripheral and central administration of neuropeptide Y in a rat middle cerebral artery occlusion stroke model reduces cerebral blood flow and increases infarct volume.

Authors:  Shao-Hua Chen; Raymond T F Cheung
Journal:  Brain Res       Date:  2002-02-15       Impact factor: 3.252

Review 2.  The role of neuropeptide Y in cardiovascular regulation.

Authors:  P Walker; E Grouzmann; M Burnier; B Waeber
Journal:  Trends Pharmacol Sci       Date:  1991-03       Impact factor: 14.819

3.  Differentiating ischemic from hemorrhagic stroke using plasma biomarkers: the S100B/RAGE pathway.

Authors:  Joan Montaner; Maite Mendioroz; Pilar Delgado; Teresa García-Berrocoso; Dolors Giralt; Cristina Merino; Marc Ribó; Anna Rosell; Anna Penalba; Israel Fernández-Cadenas; Francisco Romero; Carlos Molina; Jose Alvarez-Sabín; Mar Hernández-Guillamon
Journal:  J Proteomics       Date:  2012-02-11       Impact factor: 4.044

4.  Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function.

Authors:  J M Lundberg; L Terenius; T Hökfelt; C R Martling; K Tatemoto; V Mutt; J Polak; S Bloom; M Goldstein
Journal:  Acta Physiol Scand       Date:  1982-12

5.  Changes in neuropeptide Y protein expression following photothrombotic brain infarction and epileptogenesis.

Authors:  Elena A Kharlamov; Alexander Kharlamov; Kevin M Kelly
Journal:  Brain Res       Date:  2006-11-22       Impact factor: 3.252

Review 6.  Risk factors in stroke.

Authors:  P Mustacchi
Journal:  West J Med       Date:  1985-08

7.  Association of the C-399T promoter polymorphism of neuropeptide Y with susceptibility to ischemic stroke.

Authors:  No S Kim; Se-Mi Oh; Mi M Ko; Min H Cha; Byoung K Kang; Ok S Bang
Journal:  Clin Biochem       Date:  2009-07-17       Impact factor: 3.281

8.  Association between a novel polymorphism in the promoter region of the neuropeptide Y gene and schizophrenia in humans.

Authors:  Masanari Itokawa; Makoto Arai; Shuhei Kato; Yoko Ogata; Aizo Furukawa; Seiichi Haga; Hiroshi Ujike; Ichiro Sora; Kazuhiko Ikeda; Takeo Yoshikawa
Journal:  Neurosci Lett       Date:  2003-08-28       Impact factor: 3.046

9.  An interactive association of common sequence variants in the neuropeptide Y gene with susceptibility to ischemic stroke.

Authors:  Chaeyoung Lee; Minyoung Kong
Journal:  Stroke       Date:  2007-08-16       Impact factor: 7.914

10.  Neuropeptide Y stimulates proliferation of human vascular smooth muscle cells: cooperation with noradrenaline and ATP.

Authors:  D Erlinge; J Brunkwall; L Edvinsson
Journal:  Regul Pept       Date:  1994-03-17
View more
  2 in total

Review 1.  Assessed and Emerging Biomarkers in Stroke and Training-Mediated Stroke Recovery: State of the Art.

Authors:  Marialuisa Gandolfi; Nicola Smania; Antonio Vella; Alessandro Picelli; Salvatore Chirumbolo
Journal:  Neural Plast       Date:  2017-03-08       Impact factor: 3.599

2.  Neuropeptide Y as a risk factor for cardiorenal disease and cognitive dysfunction in chronic kidney disease: translational opportunities and challenges.

Authors:  Carmine Zoccali; Alberto Ortiz; Inga Arune Blumbyte; Sarina Rudolf; Annette G Beck-Sickinger; Jolanta Malyszko; Goce Spasovski; Sol Carriazo; Davide Viggiano; Justina Kurganaite; Vaiva Sarkeviciene; Daiva Rastenyte; Andreja Figurek; Merita Rroji; Christopher Mayer; Mustapha Arici; Gianvito Martino; Gioacchino Tedeschi; Annette Bruchfeld; Belinda Spoto; Ivan Rychlik; Andrzej Wiecek; Mark Okusa; Giuseppe Remuzzi; Francesca Mallamaci
Journal:  Nephrol Dial Transplant       Date:  2021-12-28       Impact factor: 5.992

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.